Edward Harvey, PhD
@epharvey3
Harvard Chemical Biology Ph.D. Walensky lab graduate student. Kruse lab postdoctoral fellow @HMS_BCMP. @Arenabioworks antibody engineer. Views are my own.
ID: 2683818271
27-07-2014 01:30:54
186 Tweet
129 Followers
147 Following
Congratulations to Matt McHenry & the entire team, including collaborators Jim Wells Gygi Lab John R. Engen Thomas Wales, on the discovery of a covalent inhibitor of BAX, a blueprint for developing drugs to protect cells from unwanted cell death. nature.com/articles/s4158…
I am excited to share my first project in @jwadeharperlab for feedback. We used spatiotemporal proteomics (1) to describe how cells respond to NLRP3 agonists and (2) to profile the proximal proteome as NLRP3 trafficks to the site of inflammasome nucleation harperlab.pubpub.org/pub/nlrp3/
We are looking for a couple of Research Technicians to join us in the Fischer Lab! If you enjoy biochemistry/chem bio and are interested in working in a great team exploring degrader induced interactions and degradation reach out or apply: careers.dana-farber.org/job/research-t… Please RT!
Please RT: The Walter lab at Harvard seeks computational biologists to extend our work using AlphaFold to find new protein-protein interactions. Contact [email protected] biorxiv.org/content/10.110… predictomes.org
I'm excited to share my manuscript describing our new insights into how Notch signaling induces transcription of target genes. Thanks to BlacklowLab and AdelmanLab and all co-authors! biorxiv.org/content/10.110…
Introducing the newly minted Dr. Landau! She capped off a remarkable career at Harvard with a brilliant thesis defense. Congrats Lauren! Harvard Medical School BBS at Harvard
Congratulations to Sophia Tang and the entire collaborative team from the Walensky and Segal labs on the publication of a new strategy to tackle chemotherapy-induced peripheral neuropathy by targeting the IP3 receptor with a BCL-w BH4 mimetic CellChemicalBiology cell.com/cell-chemical-…
Here we report the in silico discovery of functional MRGPRX2 antagonist nanobodies using AlphaFold2-Multimer. Thanks for the collaboration Katherine Susa Jeffrey S. Smith
We are delighted to see our own Stuart Schreiber recognized for his pioneering work in chemical biology, which has yielded decades of impact and much more to come! Congrats Stuart and Dr. Peter G. Schultz on receiving the The Welch Foundation #WelchAward
Happy to share the peer-reviewed and updated version of our work on OrthoRep-driven evolution of aaRSs for genetic code expansion with unnatural amino acids. Congrats to Yuichi FURUHATA, a true master bioengineer, on leading this excellent work! nature.com/articles/s4146…
I’m excited to team again with my long-time friend and colleague @HarveyJBerger at Arena BioWorks. We can already feel the magic of the Ariad days as we translate Arena discoveries to high-impact medicines
Exciting news from Arena! Harvey Berger @HarveyJBerger is now CEO and chairman and Stuart Schreiber Stuart Schreiber is now CSO. I'm looking forward to seeing this dynamic duo in action delivering on our company's mission to provide impactful medicines to patients in need (1/2)